Trial Profile
An Evaluation of Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological Adverse Events and Improve Quality of Life
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Apr 2020
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 20 Apr 2020 Status changed from recruiting to completed.
- 24 Sep 2019 Planned End Date changed from 1 Sep 2019 to 1 Mar 2020.
- 24 Sep 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Dec 2019.